Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | HTR2A | P28223 | 3/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SCN4A | P35499 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1100965 | 0.83 | LMNA (0.48) | SMN1; SMN2MEN1OPRM1OPRD1KMT2A | |
| SCHEMBL11388660 | 0.79 | GSR (0.36) | CA12CA1CA2CA9HTR2A | |
| SCHEMBL9638782 | 0.78 | HRH1 (0.45) | CA12CA1CA2CA9HTR2A | |
| SCHEMBL466504 | 0.75 | HRH1 (0.48) | HTR2AHRH1MEN1OPRM1OPRD1 | |
| SCHEMBL6151738 | 0.73 | CA12 (0.47) | CA12CA1CA2CA9HTR2A | |
| SCHEMBL11124054 | 0.72 | HRH1 (0.46) | HTR2AHRH1 | |
| SCHEMBL11795957 | 0.72 | HRH1 (0.46) | HTR2AHRH1 | |
| SCHEMBL9446574 | 0.72 | HRH1 (0.46) | HTR2AHRH1 | |
| SCHEMBL11403346 | 0.72 | HRH1 (0.46) | HTR2AHRH1 | |
| SCHEMBL1406142 | 0.72 | HRH1 (0.46) | HTR2AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112745497-A | Semi-aromatic polyamide resin and preparation method and application thereof | 南京开创新材料科技有限公司 | 2021-05-04 | — | — | CN | claimed |
| CN-112679728-A | Semi-aromatic polyamide resin and preparation method thereof | 南京开创新材料科技有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-119406454-A | Phosphorus-containing porous organic polymer supported nickel catalyst and preparation method thereof | 兰州大学 | 2025-02-11 | — | — | CN | disclosed |
| US-12043721-B2 | Antiviral/antimicrobial polymer compositions, fibers, and products | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2024-07-23 | — | — | US | disclosed |
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) | 2024-01-04 | — | — | US | disclosed |
| CN-117098749-A | [11C] Labeled acyclic retinoids, central nervous system activators and methods for their manufacture | 国立研究开发法人国立长寿医疗研究中心 | 2023-11-21 | — | — | CN | disclosed |
| EP-4249058-A1 | [11C]-LABELLED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | National Center for Geriatrics and Gerontology (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-20230234917-A1 | ASPARAGINE DERIVATIVES AND METHODS OF USING SAME | SENDA BIOSCIENCES INC (US) | 2023-07-27 | — | — | US | disclosed |
| WO-2021252640-A1 | ASPARAGINE DERIVATIVES AND METHODS OF USING SAME | SENDA BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| CN-106661065-B | Crystal of cyclic phosphonic acid sodium salt and method for producing same | 大塚化学株式会社 | 2021-09-24 | — | — | CN | disclosed |
| US-20210246256-A1 | POLYURETHANE FOAM OR POLYETHER POLYOL STABILIZED WITH A BENZOFURANONE-PHOSPHITE DERIVATIVE | BASF SE (DE) | 2021-08-12 | — | — | US | disclosed |
| EP-0197311-B1 | PROCESS FOR POLYMERIZING ETHYLENE | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-12-18 | — | — | EP | disclosed |
| US-4762898-A | Process for polymerizing ethylene | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1988-08-09 | — | — | US | disclosed |
| EP-0267794-A2 | Process for preparing polyolefins | Nippon Petrochemicals Co., Ltd. (JP) | 1988-05-18 | — | — | EP | disclosed |
| EP-0197311-A2 | Process for polymerizing ethylene | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1986-10-15 | — | — | EP | disclosed |
| US-4525555-A | TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS | NIPPON OIL COMPANY, LIMITED (JP) | 1985-06-25 | — | — | US | disclosed |
| US-4135045-A | PROCESS FOR POLYMERIZATION OF OLEFINS AND CATALYST COMPOSITION THEREFOR | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-01-16 | — | — | US | disclosed |
| US-4067903-A | Manufacture of arylamines | BASF AKTIENGESELLSCHAFT (DT) | 1978-01-10 | — | — | US | disclosed |
| US-4048415-A | TITANIUM-ALUMINUM COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1977-09-13 | — | — | US | disclosed |
| US-4036809-A | Halogen-containing diphosphonates | ETHYL CORPORATION (US) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NR2E3, FABP7, RARB | CA12 459/4885CA1 355/4885CA2 2385/4885 |
| US-20230234917-A1 | ASPARAGINE DERIVATIVES AND METHODS OF USING SAME | ASNS, SI, NARS1 | CA12 2200/4885CA1 1055/4885CA2 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.